Atossa Therapeutics
ATOS
ATOS
45 hedge funds and large institutions have $11.9M invested in Atossa Therapeutics in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
59% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 17
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Holders
45
Holding in Top 10
–
Calls
$779K
Puts
$64K
Top Buyers
| 1 | +$66.2K | |
| 2 | +$9.29K | |
| 3 | +$7.88K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.63K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.3K |
Top Sellers
| 1 | -$472K | |
| 2 | -$186K | |
| 3 | -$105K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$100K |
| 5 |
Millennium Management
New York
|
-$72.2K |